1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. Headlines
  1. New Morningstar Analyst Report for DaVita HealthCare Partners Inc

    Stock Reports

    Mon, 25 Aug 2014

    DaVita 's profitability is largely dependent on ..... paying exchange plans could adversely affect DaVita 's bottom line.Federal government changes ..... Amgen's Epogen could eventually improve DaVita 's profitability. Management has historically

  2. A Shift in Health-Care M&A Activity


    Sat, 23 Aug 2014

    Speaking of diabetes, how do you view DaVita HealthCare Partners DVA as a potential ..... a certain amount of attractiveness for DaVita in that diabetes is a big contributor to dialysis and DaVita is one of the largest dialysis providers

  3. Update: NxStage Medical Earnings


    Wed, 13 Aug 2014

    compared to its previous guidance of $283 to $288 million. Although established players like Fresenius (NYSE: FMS ) and DaVita (NYSE: DVA ) account for more than half of the conventional dialysis market segment in the US, NxStage Medical's System

  4. Update: DaVita Is Still Undervalued, Despite Headwinds


    Mon, 4 Aug 2014

    By Early Retiree : On July 31 DaVita (NYSE: DVA ) delivered a mixed bag of ..... management. These issues prompted Kent Thiry, DaVita 's CEO, to step in personally to run ..... legacy business will continue to do well. DaVita now expects 2014 consolidated operating

  5. Kidney Care Remains DaVita ’s Bright Spot in a Tough Environment


    Fri, 1 Aug 2014

    Despite weakness in both of DaVita HealthCare Partners’ business segments, the ..... reduction in administrative costs, DaVita upheld healthy segment operating margin ..... treatment growth to remain strong for DaVita . We also expect profitability to improve

  6. DaVita HealthCare Partners' (DVA) CEO Kent Thiry on Q2 2014 Results - Earnings Call Transcript


    Thu, 31 Jul 2014

    DaVita HealthCare Partners (NYSE: DVA ) Q2 2014 Earnings Call July 31, 2014 5 ..... conference coordinator today. At this time, I would like to welcome everyone to DaVita HealthCare Partners Second Quarter 2014 Earnings Call. [Operator Instructions

  7. DaVita updated guidance after Q2 results


    Thu, 31 Jul 2014

    DaVita HealthCare Partners ( DVA -1.2% ) Q2 results : Total Net Revenues: $3,172.5M (+10.5%); Operating Expenses

  8. Fresenius Meets Expectations and Cautiously Enters Coordinated-Care Market


    Thu, 31 Jul 2014

    Illinois and Texas. We're usually skeptical of deals outside of management's expertise in dialysis, a criticism we share with DaVita 's large merger with Healthcare Partners. While we think Fresenius' global dominance in the dialysis market is enough to

  9. DaVita chief resigns effective August 1


    Mon, 21 Jul 2014

    Shares of DaVita HealthCare Partners ( DVA -3.7% ) are down on modestly higher volume after the company announced that CEO Dr. Craig Samitt

  10. Addition of Verizon and Trimming of GM Most Notable Changes in Berkshire's 1Q Portfolio


    Thu, 15 May 2014

    in March 2009. The only other notable additions during the period was the purchase of an additional 1.2 million shares of DaVita (for $75 million), 233,000 shares of IBM (for $45 million), 724,000 shares of VeriSign (for $40 million), and

« Prev12345Next »
Content Partners